| Philip Mcardle, | |
|
1717 6th Ave S, Birmingham, AL 35233-1801 | |
| (800) 822-8816 | |
| Not Available |
| Full Name | Philip Mcardle |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | 1717 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396833927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 19020 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
A new study led by University of Iowa researchers has found an unexpected new link between this inflammation in heart muscle following a heart attack and a previously known enzyme called calcium/calmodulin-dependent protein kinase II or CaM kinase II.
A study conducted by researchers in Finland suggests that children who are exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools are unlikely to transmit the virus further and play any significant role in the spread of coronavirus disease 2019 (COVID-19).
When it comes to inpatient treatment of a range of mental health and mood disorders - from anxiety and depression to schizophrenia, suicidality and acute psychotic episodes - a new study advocates for exercise, rather than psychotropic medications, as the primary prescription and method of intervention.
Chapman has signed a formal agreement to collaborate with the Center for Autism and Related Disorders (CARD), one of the world's largest organizations treating autism spectrum disorder (ASD) and the third largest non-governmental organization contributing to autism research in the United States.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the initiation of a Phase III clinical trial for TAK-700 in the U.S. in patients with advanced prostate cancer. TAK-700 is a selective, oral, non-steroidal androgen synthesis inhibitor that in preclinical studies has been shown to selectively bind to and inhibit the enzyme 17,20 lyase in both the testes and adrenal glands.
› Verified 8 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
A new study led by University of Iowa researchers has found an unexpected new link between this inflammation in heart muscle following a heart attack and a previously known enzyme called calcium/calmodulin-dependent protein kinase II or CaM kinase II.
A study conducted by researchers in Finland suggests that children who are exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools are unlikely to transmit the virus further and play any significant role in the spread of coronavirus disease 2019 (COVID-19).
When it comes to inpatient treatment of a range of mental health and mood disorders - from anxiety and depression to schizophrenia, suicidality and acute psychotic episodes - a new study advocates for exercise, rather than psychotropic medications, as the primary prescription and method of intervention.
Chapman has signed a formal agreement to collaborate with the Center for Autism and Related Disorders (CARD), one of the world's largest organizations treating autism spectrum disorder (ASD) and the third largest non-governmental organization contributing to autism research in the United States.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the initiation of a Phase III clinical trial for TAK-700 in the U.S. in patients with advanced prostate cancer. TAK-700 is a selective, oral, non-steroidal androgen synthesis inhibitor that in preclinical studies has been shown to selectively bind to and inhibit the enzyme 17,20 lyase in both the testes and adrenal glands.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip Mcardle, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | Philip Mcardle, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
A new study led by University of Iowa researchers has found an unexpected new link between this inflammation in heart muscle following a heart attack and a previously known enzyme called calcium/calmodulin-dependent protein kinase II or CaM kinase II.
A study conducted by researchers in Finland suggests that children who are exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools are unlikely to transmit the virus further and play any significant role in the spread of coronavirus disease 2019 (COVID-19).
When it comes to inpatient treatment of a range of mental health and mood disorders - from anxiety and depression to schizophrenia, suicidality and acute psychotic episodes - a new study advocates for exercise, rather than psychotropic medications, as the primary prescription and method of intervention.
Chapman has signed a formal agreement to collaborate with the Center for Autism and Related Disorders (CARD), one of the world's largest organizations treating autism spectrum disorder (ASD) and the third largest non-governmental organization contributing to autism research in the United States.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the initiation of a Phase III clinical trial for TAK-700 in the U.S. in patients with advanced prostate cancer. TAK-700 is a selective, oral, non-steroidal androgen synthesis inhibitor that in preclinical studies has been shown to selectively bind to and inhibit the enzyme 17,20 lyase in both the testes and adrenal glands.
› Verified 8 days ago
Riaz Mohammed Karukappadath, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Dr. Victor E. Mendoza, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5130 Cyrus Cir, Birmingham, AL 35242 Phone: 205-981-0414 | |
Joshua Edward Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Stacy Wade, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Bernis A Simmons, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 52 Medical Park Dr E, Suite 321, Birmingham, AL 35235 Phone: 205-838-3055 Fax: 205-838-3517 | |
George R. Wells Iii, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1201 11th Ave S, Birmingham, AL 35205 Phone: 205-930-7246 | |
Teddy W. Sartin, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1600 Carraway Blvd, Birmingham, AL 35234 Phone: 205-502-6817 Fax: 205-502-5152 |